On-demand behavioral health platform Ginger.io has named Russell Glass as its next CEO. Before taking the job at Ginger.io, Glass was the CEO of a B2B marketing company called Bizo. Glass’ start date is set for Sept. 10.
“As I evaluated my next venture, I wanted to create a positive impact on people’s lives,” Glass said in a statement. “Ginger.io is a perfect fit — a phenomenal team of people...
WellDoc has expanded its BlueStar digital diabetes management platform to include a weight loss feature and a feature for those with both diabetes and hypertension. A standalone product for hypertension is also coming from the company later this year.
“The American Diabetes Association reports that nearly one in three American adults has hypertension, and two in three people with diabetes have...
The NHS is looking to ramp up its patient data security, after signing a contract with software company Privitar for its de-identification technology. The new technology will help prevent a person’s identify from being connected to their information.
“The health and care landscape is rapidly changing, and we can improve individual patient care if our systems can deliver a complete picture of...
Novo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill platform. The partnership is hoping to engage 10,000 diabetes patients on Sempre’s platform within 2018.
“Looking at some of the metrics that Sempre has been able to provide...
Samsung Health users will now have access to a new consumer-grade version of WellDoc’s digital diabetes management platform, the two companies announced this morning.
The Diabetes Wellness Program is a 12-week wellness program designed to help Type 2 diabetes patients improve unhealthy behaviors and better manage their condition. The program is available through the Samsung Health version 5.14 or...
WellDoc’s digital diabetes management therapeutic BlueStar will now be available on the Solera network as a diabetes management option.
Phoenix, Arizona-based Solera Health, a platform which offers a marketplace for chronic disease management programs, and digital therapeutic maker WellDoc announced the partnership today, and said that the partnership aligns both companies' goals to improve the...
Correction: A previous version of this story mistated the projected timeline for the combined product. It is Q1 this year, not Q1 next year.
WellDoc and Voluntis, two companies with FDA-cleared, clinically validated platforms aimed at the management of Type 2 diabetes, have signed a commercial agreement to combine their technologies and offer joint products in the future.
“My thought is that a...
An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month.
“The cost of a well-controlled diabetes patient will typically range in the $13,000 range [to] $20,000 annually. When you contrast that with the cost of a patient that doesn’t have diabetes, that number is typically...
A group of health startups in the burgeoning digital therapeutics space have joined together to create a new industry association, the Digital Therapeutics Alliance (DTA).
“Digital therapeutics are re-writing our definition of medicine,” Akili Interactive CEO Eddie Martucci said in a statement. “It’s critical that industry, academia, government, and the medical community work together in the...
AmalgamRx, a newly unstealthed company founded by WellDoc founders Ryan Sysko and Dr. Suzanne Clough, has received FDA clearance for iSage, an insulin titration algorithm.
“One of the big challenges with insulin is that it’s scary for patients, they don’t necessarily want to go on it,” Sysko told MobiHealthNews. “So we wanted to find a way to help them optimize their insulin regimen and get to...
